John Suk
Corporate Officer/Principal en Altmax Consulting .
Perfil
John Suk is currently the owner of Altmax Consulting.
Previously, he was the President & Chief Executive Officer of Takeda Canada, Inc. He also served as the Director of Brock University from 2006 to 2017.
In addition, he was an Independent Director at Covalon Technologies Ltd., Director at The Canadian Health Services Research Foundation, Director at Exciton Technologies, Inc., Director at Medical Futures, Inc., and Director at Innovate Niagara.
Mr. Suk received his undergraduate degree from Brock University.
Cargos activos de John Suk
Empresas | Cargo | Inicio |
---|---|---|
Altmax Consulting | Corporate Officer/Principal | - |
Antiguos cargos conocidos de John Suk.
Empresas | Cargo | Fin |
---|---|---|
Brock University | Director/Miembro de la Junta | 01/01/2017 |
The Canadian Health Services Research Foundation | Director/Miembro de la Junta | - |
Exciton Technologies, Inc.
Exciton Technologies, Inc. Medical SpecialtiesHealth Technology Exciton Technologies, Inc. operates as a Canadian materials research and development company that focuses on the creation of technologies for preventing and controlling infection. It offers exsalt SD7 wound dressing and exsalt T7 wound dressing. The company was founded by Rod Precht in 2010 and is headquartered in Edmonton, Canada. | Director/Miembro de la Junta | - |
Innovate Niagara | Director/Miembro de la Junta | - |
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Canada, Inc. is a biopharmaceutical company based in Mississauga, CA. Takeda provides financial data for investors and is focused on developing innovative medicines to make a difference in people's lives. The Canadian company is committed to discovering and delivering life-transforming treatments in the areas of oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. The company's employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. | Director Ejecutivo | - |
Formación de John Suk.
Brock University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
COVALON TECHNOLOGIES LTD. | Health Technology |
Empresas privadas | 6 |
---|---|
The Canadian Health Services Research Foundation | |
Exciton Technologies, Inc.
Exciton Technologies, Inc. Medical SpecialtiesHealth Technology Exciton Technologies, Inc. operates as a Canadian materials research and development company that focuses on the creation of technologies for preventing and controlling infection. It offers exsalt SD7 wound dressing and exsalt T7 wound dressing. The company was founded by Rod Precht in 2010 and is headquartered in Edmonton, Canada. | Health Technology |
Medical Futures, Inc.
Medical Futures, Inc. Medical DistributorsDistribution Services Part of Searchlight Pharma, Inc., Medical Futures, Inc. sells pharmaceutical and natural therapeutic products. The company is based in Richmond Hill, Canada. Medical Futures was acquired by Aralez Pharmaceuticals Canada, Inc., part of Searchlight Pharma, Inc. from December 31, 2018 on June 17, 2015 for $20.97 million. The Canadian company was founded by Pardeep Nijhawan. The CEO is Colin Campbell. | Distribution Services |
Takeda Canada, Inc.
Takeda Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Canada, Inc. is a biopharmaceutical company based in Mississauga, CA. Takeda provides financial data for investors and is focused on developing innovative medicines to make a difference in people's lives. The Canadian company is committed to discovering and delivering life-transforming treatments in the areas of oncology, rare genetics and hematology, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. The company's employees are dedicated to improving the quality of life for patients and working with healthcare partners in approximately 80 countries and regions. | Health Technology |
Altmax Consulting | |
Innovate Niagara |
- Bolsa de valores
- Insiders
- John Suk